An official revealed that the Pharmaceuticals Export Promotion Council of India (Pharmexcil) will host a three-day pharma convention from April 24.
Titled iPHEX 2013, the convention is being organised with the support of the commerce and industry ministry, department of commerce, and the central government. The convention will have 200 stalls by Indian pharma companies and over 5,000 business visitors, including overseas buyers.
Psychoactive Pharmaceuticals: Fish Show Autism-Like Gene Expression in Water
New research says that psychoactive medications in water affect the gene expression profiles of fathead minnows
Advertisement
"Indian pharma industry would immensely get benefited as there would be over 400 genuine pharma buyers/drug regulators from various countries and exhibitors would be having one-to-one meetings with them," said P.V. Appaji, director general of Pharmexcil.
Over 40 senior regulators from 20 countries like Ghana, Tanzania, Senegal, Taiwan, Vietnam, the Philippines and others will also join the convention.
![Harmful Greenhouse Gas Converted into a Tool for Making Pharmaceuticals]( "Harmful Greenhouse Gas Converted into a Tool for Making Pharmaceuticals")
A way to transform a useless ozone-destroying greenhouse gas into a reagent for producing pharmaceuticals has been identified.
Bhavin Mehta, committee chief of iPHEX, said that the convention will be a platform to showcase the diverse range of products.
"Technical seminars will be organised during the convention where the invited drug regulators will make presentations on drug regulatory procedures of their countries," he said.
Source: IANS
Harmful Greenhouse Gas Converted into a Tool for Making Pharmaceuticals
A way to transform a useless ozone-destroying greenhouse gas into a reagent for producing pharmaceuticals has been identified.
Advertisement
Bhavin Mehta, committee chief of iPHEX, said that the convention will be a platform to showcase the diverse range of products.
"Technical seminars will be organised during the convention where the invited drug regulators will make presentations on drug regulatory procedures of their countries," he said.
Source: IANS
FDA Approves Aegerion Pharmaceuticals’ Drug for a Cholesterol Disorder
Aegerion Pharmaceuticals' have come out with a novel drug used to treat a rare disease that causes extremely high levels of bad cholesterol. This drug has now received the nod by FDA.
Advertisement
 Costs of Household Products, Pharmaceuticals Could be Cut by New DeviceNanoscale packages could actually result in huge cost savings. | Advertisement
|
Advertisement
Recommended Readings
Latest General Health News
The Brain Care Score is a tool to evaluate brain health and reduce the risk of brain disorders including dementia and stroke.
Swine influenza A viruses, including subtypes H1N1, H1N2, and H3N2, are prominent among pigs and sporadically transmit to humans.
The microorganism "is a newly identified potential disease-causing agent, possibly originating from or evolving within the dog's microbiome."
Flavanol naturally present in red wine can compromise the proper metabolism of alcohol and lead to a headache.
To reduce bacterial risks, pet owners can switch to a non-raw diet or obtain quality raw meat for cooking before feeding dogs.